Key facts
- This page summarizes Mark Leonard Singleton's Form 3 filing for Bioventus Inc. (BVS).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 25 Mar 2022, 20:00.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Title: Senior Vice President and Chief Financial Officer; Exhibit List: Exhibit 24 - Power of Attorney